Bristol Myers Squibb licenses amyloid-beta antibody programme
By Catherine Eckford (European Pharmaceutical Review)
Adopting AI for R&D in 2025 – what needs to be addressed?
By Dr Vladimir Makarov (The Pistoia Alliance), European Pharmaceutical Review
CHMP recommends novel long-acting HIV treatment
By Catherine Eckford (European Pharmaceutical Review)
Novo Nordisk investing in rare disease with major new manufacturing site
By Catherine Eckford (European Pharmaceutical Review)
Adopting AI for R&D in 2025 – what needs to…
By Dr Vladimir Makarov (The Pistoia Alliance), European Pharmaceutical Review